期刊论文详细信息
Biomedicinska istraživanja
Neoadjuvant therapy for HER2-positive breast cancer
Zdenka Gojković1  Nikolina Dukić2  Olivera Čančar3  Srdjan Mašić3  Jelena Vladičić-Mašić3  Sladjana Popović3  Dragana Jokanović3  Nenad Lalović3 
[1] University Clinical Center of the Republic Srpska, Clinics in Oncology, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina;University Hospital Foča, Center for Internal Medicine, The Republic of Srpska, Bosnia and Herzegovina;University of East Sarajevo, The Faculty of Medicine, Foča, The Republic of Srpska, Bosnia and Herzegovina;
关键词: breast carcer;    HER2 receptor;    neoadjuvant therapy;    pCR;    trastuzumab;    pertuzumab;   
DOI  :  doi:10.7251/BII1901083D
来源: DOAJ
【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次